You are here

Home › Listings › Life Sciences › MedMen Enterprises Inc. Class B Subordinate Voting Shares

MedMen Enterprises Inc. Class B Subordinate Voting Shares

MedMen Enterprises Inc. Class B Subordinate Voting Shares
Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
MMEN
CSE Index: 
Currency: 

MedMen is a cannabis retailer with flagship locations in California, Nevada, Illinois, Florida, and New York. MedMen offers a robust selection of high-quality products, including MedMen-owned brands [statemade], LuxLyte, and MedMen Red through its premium retail stores, proprietary delivery service, as well as curbside and in-store pick up. MedMen Buds, the Company’s loyalty program, provides exclusive access to promotions, product drops and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier and happier. Learn more about MedMen and The MedMen Foundation at www.medmen.com.

You are here

Home

MedMen Enterprises Inc. Class B Subordinate Voting Shares (MMEN)

SEDAR Information

Search form

Company Info

Address
10115 Jefferson Boulevard
Culver City, CA 90232
United States
Phone
855-292-8399
Email
investors@medmen.com
Website
http://medmen.com
Listing date
Tuesday, May 29, 2018
Transfer Agent
Odyssey Trust Company
Investor Relations
Zeeshan Hyder
Email
investors@medmen.com

Capitalization

Issued & Outstanding: 
500344220
Reserved for Issuance: 
149357759
Total equity shares, as if converted: 
649701980

Company Officers

Tom Lynch, Chief Executive Officer
Zeeshan Hyder, Chief Financial Officer

News Releases

17/05/2021

MedMen Announces Private Placement and Fenway Construction

11/05/2021

MedMen Q3 2021 Earnings Press Release

Bulletins

16/05/2024

2024-0515 - Delist - MedMen Enterprises Inc. (MMEN)

le 16 mai/May 2024

The Class B Subordinate Voting Shares of MedMen Enterprises Inc. will be delisted from the CSE at market close today, May 16, 2024.

MedMen Enterprises Inc. is currently suspended. See bulletin 2024-0106.

___________________________

CSE Filings

Form 9: Notice of Issuance or Proposed Issuance of Listed Securities

Form 7 Monthly Progress Report - March 2022

Form 7 Monthly Progress Report - February 2022

Form 7 Monthly Progress Report - January 2022

Form 7 Monthly Progress Report - December 2021